Literature DB >> 28931750

Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndrome.

Anne-Lise Lecoq1,2,3, Constantine A Stratakis4, Say Viengchareun1,2, Ronan Chaligné5,6, Lucie Tosca2,7,8, Vianney Deméocq1, Mirella Hage1, Annabel Berthon4, Fabio R Faucz4, Patrick Hanna9, Hadrien-Gaël Boyer10, Nicolas Servant11,12, Sylvie Salenave3, Gérard Tachdjian2,7,8, Clovis Adam13, Vanessa Benhamo5,6, Eric Clauser14, Anne Guiochon-Mantel1,2,15, Jacques Young1,2,3, Marc Lombès1,2,3, Isabelle Bourdeau16, Dominique Maiter17, Antoine Tabarin18, Jérôme Bertherat19, Hervé Lefebvre10, Wouter de Herder20, Estelle Louiset10, André Lacroix16, Philippe Chanson1,2,3, Jérôme Bouligand1,2,15, Peter Kamenický1,2,3.   

Abstract

GIP-dependent Cushing's syndrome is caused by ectopic expression of glucose-dependent insulinotropic polypeptide receptor (GIPR) in cortisol-producing adrenal adenomas or in bilateral macronodular adrenal hyperplasias. Molecular mechanisms leading to ectopic GIPR expression in adrenal tissue are not known. Here we performed molecular analyses on adrenocortical adenomas and bilateral macronodular adrenal hyperplasias obtained from 14 patients with GIP-dependent adrenal Cushing's syndrome and one patient with GIP-dependent aldosteronism. GIPR expression in all adenoma and hyperplasia samples occurred through transcriptional activation of a single allele of the GIPR gene. While no abnormality was detected in proximal GIPR promoter methylation, we identified somatic duplications in chromosome region 19q13.32 containing the GIPR locus in the adrenocortical lesions derived from 3 patients. In 2 adenoma samples, the duplicated 19q13.32 region was rearranged with other chromosome regions, whereas a single tissue sample with hyperplasia had a 19q duplication only. We demonstrated that juxtaposition with cis-acting regulatory sequences such as glucocorticoid response elements in the newly identified genomic environment drives abnormal expression of the translocated GIPR allele in adenoma cells. Altogether, our results provide insight into the molecular pathogenesis of GIP-dependent Cushing's syndrome, occurring through monoallelic transcriptional activation of GIPR driven in some adrenal lesions by structural variations.

Entities:  

Keywords:  Endocrinology; Molecular pathology

Mesh:

Substances:

Year:  2017        PMID: 28931750      PMCID: PMC5621881          DOI: 10.1172/jci.insight.92184

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  39 in total

1.  Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome.

Authors:  A Lacroix; E Bolté; J Tremblay; J Dupré; P Poitras; H Fournier; J Garon; D Garrel; F Bayard; R Taillefer
Journal:  N Engl J Med       Date:  1992-10-01       Impact factor: 91.245

Review 2.  Multiple aberrant hormone receptors in Cushing's syndrome.

Authors:  Nada El Ghorayeb; Isabelle Bourdeau; André Lacroix
Journal:  Eur J Endocrinol       Date:  2015-05-13       Impact factor: 6.664

3.  Integrated genomic analysis of nodular tissue in macronodular adrenocortical hyperplasia: progression of tumorigenesis in a disorder associated with multiple benign lesions.

Authors:  Madson Q Almeida; Michelle Harran; Eirini I Bimpaki; Hui-Pin Hsiao; Anelia Horvath; Chris Cheadle; Tonya Watkins; Maria Nesterova; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2011-01-20       Impact factor: 5.958

4.  Expression of serotonin7 receptor and coupling of ectopic receptors to protein kinase A and ionic currents in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome.

Authors:  Estelle Louiset; Vincent Contesse; Lionel Groussin; Dorthe Cartier; Céline Duparc; Gaëlle Barrande; Jérôme Bertherat; Hubert Vaudry; Hervé Lefebvre
Journal:  J Clin Endocrinol Metab       Date:  2006-09-05       Impact factor: 5.958

5.  Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation.

Authors:  Giampaolo Trivellin; Adrian F Daly; Fabio R Faucz; Bo Yuan; Liliya Rostomyan; Darwin O Larco; Marie Helene Schernthaner-Reiter; Eva Szarek; Letícia F Leal; Jean-Hubert Caberg; Emilie Castermans; Chiara Villa; Aggeliki Dimopoulos; Prashant Chittiboina; Paraskevi Xekouki; Nalini Shah; Daniel Metzger; Philippe A Lysy; Emanuele Ferrante; Natalia Strebkova; Nadia Mazerkina; Maria Chiara Zatelli; Maya Lodish; Anelia Horvath; Rodrigo Bertollo de Alexandre; Allison D Manning; Isaac Levy; Margaret F Keil; Maria de la Luz Sierra; Leonor Palmeira; Wouter Coppieters; Michel Georges; Luciana A Naves; Mauricette Jamar; Vincent Bours; T John Wu; Catherine S Choong; Jerome Bertherat; Philippe Chanson; Peter Kamenický; William E Farrell; Anne Barlier; Martha Quezado; Ivana Bjelobaba; Stanko S Stojilkovic; Jurgen Wess; Stefano Costanzi; Pengfei Liu; James R Lupski; Albert Beckers; Constantine A Stratakis
Journal:  N Engl J Med       Date:  2014-12-03       Impact factor: 91.245

6.  Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing's syndrome.

Authors:  N N'Diaye; J Tremblay; P Hamet; W W De Herder; A Lacroix
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

7.  A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.

Authors:  R P Lifton; R G Dluhy; M Powers; G M Rich; S Cook; S Ulick; J M Lalouel
Journal:  Nature       Date:  1992-01-16       Impact factor: 49.962

8.  Activating hotspot L205R mutation in PRKACA and adrenal Cushing's syndrome.

Authors:  Yanan Cao; Minghui He; Zhibo Gao; Ying Peng; Yanli Li; Lin Li; Weiwei Zhou; Xiangchun Li; Xu Zhong; Yiming Lei; Tingwei Su; Hang Wang; Yiran Jiang; Lin Yang; Wei Wei; Xu Yang; Xiuli Jiang; Li Liu; Juan He; Junna Ye; Qing Wei; Yingrui Li; Weiqing Wang; Jun Wang; Guang Ning
Journal:  Science       Date:  2014-04-03       Impact factor: 47.728

9.  Pregnancy, Primary Aldosteronism, and Adrenal CTNNB1 Mutations.

Authors:  Ada E D Teo; Sumedha Garg; Lalarukh Haris Shaikh; Junhua Zhou; Fiona E Karet Frankl; Mark Gurnell; Lisa Happerfield; Alison Marker; Mariann Bienz; Elena A B Azizan; Morris J Brown
Journal:  N Engl J Med       Date:  2015-09-23       Impact factor: 91.245

10.  Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors.

Authors:  Gerald Goh; Ute I Scholl; James M Healy; Murim Choi; Manju L Prasad; Carol Nelson-Williams; John W Kunstman; John W Kuntsman; Reju Korah; Anna-Carinna Suttorp; Dimo Dietrich; Matthias Haase; Holger S Willenberg; Peter Stålberg; Per Hellman; Göran Akerström; Peyman Björklund; Tobias Carling; Richard P Lifton
Journal:  Nat Genet       Date:  2014-04-20       Impact factor: 38.330

View more
  12 in total

Review 1.  Adrenocortical tumorigenesis: Lessons from genetics.

Authors:  Crystal D C Kamilaris; Fady Hannah-Shmouni; Constantine A Stratakis
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2020-05-23       Impact factor: 4.690

Review 2.  The pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes.

Authors:  Daniela Regazzo; Mattia Barbot; Carla Scaroni; Nora Albiger; Gianluca Occhi
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

3.  High expression of adrenal P450 aromatase (CYP19A1) in association with ARMC5-primary bilateral macronodular adrenocortical hyperplasia.

Authors:  Annabel Berthon; Fady Hannah-Shmouni; Andrea Gutierrez Maria; Fabio R Faucz; Constantine A Stratakis
Journal:  J Steroid Biochem Mol Biol       Date:  2019-04-20       Impact factor: 4.292

Review 4.  Genetics of Cushing's Syndrome.

Authors:  Laura C Hernández-Ramírez; Constantine A Stratakis
Journal:  Endocrinol Metab Clin North Am       Date:  2018-06       Impact factor: 4.741

Review 5.  Cushing syndrome: Old and new genes.

Authors:  Christina Tatsi; Chelsi Flippo; Constantine A Stratakis
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2020-04-02       Impact factor: 4.690

6.  ARMC5 variants in PRKAR1A-mutated patients modify cortisol levels and Cushing's syndrome.

Authors:  Andrea Gutierrez Maria; Christina Tatsi; Annabel Berthon; Ludivine Drougat; Nikolaos Settas; Fady Hannah-Shmouni; Jerome Bertherat; Fabio R Faucz; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2020-09       Impact factor: 5.900

Review 7.  Advances in adrenal tumors 2018.

Authors:  J Crona; F Beuschlein; K Pacak; B Skogseid
Journal:  Endocr Relat Cancer       Date:  2018-07       Impact factor: 5.678

8.  Coexistence of Myelolipoma and Primary Bilateral Macronodular Adrenal Hyperplasia With GIP-Dependent Cushing's Syndrome.

Authors:  Stéphanie Larose; Louis Bondaz; Livia M Mermejo; Mathieu Latour; Odile Prosmanne; Isabelle Bourdeau; André Lacroix
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-11       Impact factor: 5.555

9.  Aldosterone is Aberrantly Regulated by Various Stimuli in a High Proportion of Patients with Primary Aldosteronism.

Authors:  Matthieu St-Jean; Isabelle Bourdeau; Marc Martin; André Lacroix
Journal:  J Clin Endocrinol Metab       Date:  2021-01-01       Impact factor: 5.958

Review 10.  An update on adrenal endocrinology: significant discoveries in the last 10 years and where the field is heading in the next decade.

Authors:  Crystal D C Kamilaris; Constantine A Stratakis
Journal:  Hormones (Athens)       Date:  2018-11-19       Impact factor: 2.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.